Co-Authors
This is a "connection" page, showing publications co-authored by Robert Axon and David Taber.
Connection Strength
0.731
-
Impact of Pharmacist-Driven Transitions of Care Interventions on Post-hospital Outcomes Among Patients With Coronary Artery Disease: A Systematic Review. J Pharm Pract. 2021 Dec 28; 8971900211064155.
Score: 0.203
-
The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes. Ann Pharmacother. 2019 07; 53(7):675-682.
Score: 0.166
-
The Magnitude and Potential Causes of Sex Disparities in Statin Therapy in Veterans with Type 2 Diabetes: A 10-year Nationwide Longitudinal Cohort Study. Womens Health Issues. 2022 May-Jun; 32(3):274-283.
Score: 0.051
-
Advanced models for improved prediction of opioid-related overdose and suicide events among Veterans using administrative healthcare data. Health Serv Outcomes Res Methodol. 2022; 22(2):275-295.
Score: 0.050
-
Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study. BMC Cardiovasc Disord. 2020 10 15; 20(1):449.
Score: 0.047
-
An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems. J Manag Care Spec Pharm. 2020 Sep; 26(9):1090-1098.
Score: 0.046
-
Impact of Race and Location of Residence on Statin Treatment Among Veterans With Type 2 Diabetes Mellitus. Am J Cardiol. 2020 05 15; 125(10):1492-1499.
Score: 0.045
-
Racial-Geographic Disparity in Lipid Management in Veterans with Type 2 Diabetes: A 10-Year Retrospective Cohort Study. Health Equity. 2019; 3(1):472-479.
Score: 0.043
-
Investigating the Potential for Bias When Using a Widely Accepted Medication Adherence Measure to Predict Mortality. Pharmacotherapy. 2018 11; 38(11):1086-1094.
Score: 0.040
-
Ethnic and geographic variations in multimorbidty: Evidence from three large cohorts. Soc Sci Med. 2018 08; 211:198-206.
Score: 0.040